Skip to main content
. 2019 Oct 18;3(20):3002–3009. doi: 10.1182/bloodadvances.2019000147

Table 3.

Organ responses among VRD-treated patients at landmark points

Landmark point 6 mo 12 mo Overall ITT
Renal responses/progression (n = 18) (n = 10) (n = 18)
3 (17)/3 (17) 4 (40)/3 (30) 4 (22)/3 (17)
Cardiac response/progression (NTproBNP criteria) (n = 18) (n = 18) (n = 27)
8 (44)/4 (22) 11 (61)/1 (6) 11 (41)/10 (37)*

Values represent n (%) of patients.

*

Based on NTproBNP increase sustained after the completion of therapy in 1 patient and early death in the other 9 patients.